Inhibikase Therapeutics, Inc. (IKT)

NASDAQ: IKT · Real-Time Price · USD

Compare

1.670

+0.030 (1.83%)

At close: Feb 13, 2026, 4:00 PM EST

1.650

-0.020 (-1.20%)

After-hours: Feb 13, 2026, 6:00 PM EST

Inhibikase Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	38.27	56.49	9.17	7.19	40.75	13.95
Short-Term Investments	39.05	41.05	4.09	15.86	-	-
Cash & Short-Term Investments	77.32	97.54	13.25	23.05	40.75	13.95
Cash Growth	2283.81%	636.06%	-42.51%	-43.44%	192.04%	75500.11%
Receivables	-	-	-	0.04	0.11	-
Prepaid Expenses	0.59	0.8	0.74	0.16	1.5	0.05
Other Current Assets	0.62	0.11	0.22	1.12	0.11	0.77
Total Current Assets	78.54	98.45	14.21	24.37	42.47	14.78
Property, Plant & Equipment	-	0.15	0.3	0.57	-	-
Other Long-Term Assets	1.06	-	-	-	-	-
Total Assets	79.59	98.6	14.51	24.94	42.47	14.78
Accounts Payable	0.62	0.94	0.65	1.15	1.09	1.72
Accrued Expenses	3.66	2.68	2.26	2.4	2.72	0.63
Short-Term Debt	-	-	0.38	-	-	0.04
Current Portion of Long-Term Debt	-	-	-	-	0.25	-
Current Portion of Leases	-	0.11	0.15	0.15	-	-
Current Unearned Revenue	-	-	-	-	-	2.33
Total Current Liabilities	6.7	3.73	3.44	3.7	4.05	4.72
Long-Term Debt	-	-	-	-	-	0.28
Long-Term Leases	-	-	0.09	0.21	-	-
Total Liabilities	6.7	3.73	3.53	3.9	4.05	5
Common Stock	0.07	0.07	0.01	0	0.03	0.01
Additional Paid-In Capital	202.77	189.25	77.87	68.8	68.21	24.81
Retained Earnings	-129.95	-94.42	-66.9	-47.87	-29.82	-15.03
Comprehensive Income & Other	-0	-0.04	0	0.1	-	-
Shareholders' Equity	72.9	94.87	10.98	21.04	38.42	9.78
Total Liabilities & Equity	79.59	98.6	14.51	24.94	42.47	14.78
Total Debt	-	0.11	0.62	0.35	0.25	0.32
Net Cash (Debt)	77.32	97.43	12.63	22.7	40.5	13.63
Net Cash Growth	2454.61%	671.44%	-44.36%	-43.95%	197.05%	-
Net Cash Per Share	0.86	1.09	2.10	5.37	13.35	9.96
Filing Date Shares Outstanding	90.69	90.01	6.48	4.83	4.2	1.68
Total Common Shares Outstanding	90.32	89.18	6.19	4.2	4.19	1.68
Working Capital	71.84	94.72	10.77	20.68	38.42	10.06
Book Value Per Share	0.81	1.06	1.77	5.00	9.16	5.84
Tangible Book Value	72.9	94.87	10.98	21.04	38.42	9.78
Tangible Book Value Per Share	0.81	1.06	1.77	5.00	9.16	5.84
Machinery	0.12	0.1	0.1	0.24	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q